EU5 Orthobiologic Procedures Count by Segments and Forecast to 2030

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

EU5 Orthobiologic Procedures Market Report Overview

The total number of Orthobiologic Procedures conducted in EU5 was 2,542,144 in 2022. Orthobiologic Procedures are used to improve the healing of fractured bones and injured muscles, tendons, and ligaments. They are derived from substances which are naturally found in the body.

The EU5 Orthobiologic Procedures market research report is a comprehensive databook report covering key procedures data on the EU5 Orthobiologic Procedures. It also provides procedure volumes within segments – Bone Grafts and Substitutes Procedures, Bone Growth Stimulators Procedures, Cartilage Repair Procedures, Soft Tissue Biologics Procedures, and Viscosupplementation Procedures.

 

EU5 Orthobiologic Procedures Market Segments

The key segments in the EU5 Orthobiologic Procedures market are Viscosupplementation Procedures, Bone Grafts and Substitutes Procedures, Soft Tissue Biologics Procedures, Cartilage Repair Procedures, and Bone Growth Stimulators Procedures. In 2022, Viscosupplementation Procedures led the EU5 Orthobiologic Procedures market.

Viscosupplementation Procedures: Viscosupplementation Procedure involves the replacement of synovial fluid at the joints by a Hyaluronate preparation which has viscous properties similar to the natural synovial fluid. This procedure is used for the treatment of osteoarthritis of the knee and other joints including hip, shoulder, ankle, elbow, wrist, hand, and foot.

Bone Grafts and Substitutes Procedures: This involves the use of bone graft when there is a breakage in the bone or in case of a void between or in the bones caused due to a number of factors such as age and degenerative diseases.

Soft Tissue Biologics Procedures: Soft Tissue Biologics Procedures are used to replace, reinforce, or repair tendons or ligaments that have been torn or damaged in the human body. It involves the repair of the anterior cruciate ligament (ACL), posterior cruciate ligament (PCL), rotator cuff, and Achilles tendon. The key sub-segments within this segment are Tendon Grafts Procedures and Tendon Wrapping Procedures.

EU5 Orthobiologic Procedures Market Analysis by Segments, 2022 (%)

EU5 Orthobiologic Procedures Market Analysis by Segments, 2022 (%)

For more segment insights into the EU5 Orthobiologic Procedures market, download a free report sample

EU5 Orthobiologic Procedures Market Segmentation by Countries

The countries covered in the EU5 Orthobiologic Procedures market are France, Germany, Italy, Spain, and the UK. Germany was the leading country in terms of the number of Orthobiologic Procedures conducted in EU5 in 2022, followed by France and the UK.

EU5 Orthobiologic Procedures Market Analysis by Countries, 2022 (%)

EU5 Orthobiologic Procedures Market Analysis by Countries, 2022 (%)

To gain more country insights into the EU5 Orthobiologic Procedures market, download a free report sample

EU5 Orthobiologic Procedures Market Report Overview

Market Size (2022) 2,542,144 Procedures
Forecast Period 2023-2030
Historical Period 2015-2022
Key Segments Viscosupplementation Procedures, Bone Grafts and Substitutes Procedures, Soft Tissue Biologics Procedures, Cartilage Repair Procedures, and Bone Growth Stimulators Procedures
Key Countries France, Germany, Italy, Spain, and the UK

Segments Covered in the Report 

EU5 Orthobiologic Procedures Market Segments Outlook (Number of Procedures, 2015-2030)

  • Viscosupplementation Procedures
  • Bone Grafts and Substitutes Procedures
  • Soft Tissue Biologics Procedures
    • Tendon Grafts Procedures
    • Tendon Wrapping Procedures
  • Cartilage Repair Procedures
    • Marrow Stimulation (Microfracture) Picks/Drills Procedures
    • Platelet-Rich Plasma (PRP) Injection Devices Procedures
    • Extracellular Matrix Implant Procedures
    • Intact Tissue Implants Procedures
  • Bone Growth Stimulators Procedures
    • External Bone Growth Stimulator Procedures
    • Implantable Bone Growth Stimulator Procedures

EU5 Orthobiologic Procedures Market Countries Outlook (Number of Procedures, 2015-2030)

  • France
  • Germany
  • Italy
  • Spain
  • The UK

 

Scope

This report provides procedure volume data for Orthobiologic Procedures related to the country.

Reasons to Buy

The EU5 Orthobiologic Procedures report helps you to develop:

  • Business strategies by identifying the key segments poised for strong growth in the future.
  • Market-entry and market expansion strategies.
  • Develop investment strategies by identifying the key segments expected to register strong growth in the near future.

Table of Contents

  • 1 Table of Contents

    • 1.1 List of Tables
    • 1.2 List of Figures

  • 2 Introduction

    • 2.1 What Is This Report About?
    • 2.2 Orthobiologic Procedures, Segmentation
    • 2.3 Definitions of Procedures Covered in the Report

  • 3 Orthobiologic Procedures, EU5

    • 3.1 Orthobiologic Procedures, EU5, 2015-2030
    • 3.2 Orthobiologic Procedures, EU5, 2015-2022

  • 4 Orthobiologic Procedures, France

    • 4.1 Orthobiologic Procedures, France, 2015-2030

      • 4.1.1 Bone Grafts and Substitutes Procedures, France, 2015-2030
      • 4.1.2 Bone Growth Stimulators Procedures, France, 2015-2030
      • 4.1.3 Cartilage Repair Procedures, France, 2015-2030
      • 4.1.4 Soft Tissue Biologics Procedures, France, 2015-2030

  • 5 Orthobiologic Procedures, Germany

    • 5.1 Orthobiologic Procedures, Germany, 2015-2030

      • 5.1.1 Bone Grafts and Substitutes Procedures, Germany, 2015-2030
      • 5.1.2 Bone Growth Stimulators Procedures, Germany, 2015-2030
      • 5.1.3 Cartilage Repair Procedures, Germany, 2015-2030
      • 5.1.4 Soft Tissue Biologics Procedures, Germany, 2015-2030

  • 6 Orthobiologic Procedures, Italy

    • 6.1 Orthobiologic Procedures, Italy, 2015-2030

      • 6.1.1 Bone Grafts and Substitutes Procedures, Italy, 2015-2030
      • 6.1.2 Bone Growth Stimulators Procedures, Italy, 2015-2030
      • 6.1.3 Cartilage Repair Procedures, Italy, 2015-2030
      • 6.1.4 Soft Tissue Biologics Procedures, Italy, 2015-2030

  • 7 Orthobiologic Procedures, Spain

    • 7.1 Orthobiologic Procedures, Spain, 2015-2030

      • 7.1.1 Bone Grafts and Substitutes Procedures, Spain, 2015-2030
      • 7.1.2 Bone Growth Stimulators Procedures, Spain, 2015-2030
      • 7.1.3 Cartilage Repair Procedures, Spain, 2015-2030
      • 7.1.4 Soft Tissue Biologics Procedures, Spain, 2015-2030

  • 8 Orthobiologic Procedures, United Kingdom

    • 8.1 Orthobiologic Procedures, United Kingdom, 2015-2030

      • 8.1.1 Bone Grafts and Substitutes Procedures, United Kingdom, 2015-2030
      • 8.1.2 Bone Growth Stimulators Procedures, United Kingdom, 2015-2030
      • 8.1.3 Cartilage Repair Procedures, United Kingdom, 2015-2030
      • 8.1.4 Soft Tissue Biologics Procedures, United Kingdom, 2015-2030

  • 9 Appendix

    • 9.1 Research Methodology

      • 9.1.1 Coverage
      • 9.1.2 Secondary Research
      • 9.1.3 Primary Research
      • 9.1.4 Market Modeling and Forecasting
      • 9.1.5 Company Share Analysis
      • 9.1.6 Distribution Share Analysis
      • 9.1.7 Benchmarking

    • 9.2 GlobalData Consulting
    • 9.3 Contact Us
    • 9.4 Disclaimer

Table

List of Tables

Table 1: Orthobiologic Procedures, EU5, 2015-2030 10

Table 2: Orthobiologic Procedures, EU5, 2015-2022 12

Table 3: Orthobiologic Procedures, EU5, 2023-2030 14

Table 4: Orthobiologic Procedures, France, 2015-2022 16

Table 5: Orthobiologic Procedures, France, 2023-2030 18

Table 6: Bone Grafts and Substitutes Procedures, France, 2015-2022 20

Table 7: Bone Grafts and Substitutes Procedures, France, 2023-2030 22

Table 8: Bone Growth Stimulators Procedures, France, 2015-2022 24

Table 9: Bone Growth Stimulators Procedures, France, 2023-2030 26

Table 10: Cartilage Repair Procedures, France, 2015-2022 28

Table 11: Cartilage Repair Procedures, France, 2023-2030 30

Table 12: Soft Tissue Biologics Procedures, France, 2015-2022 32

Table 13: Soft Tissue Biologics Procedures, France, 2023-2030 34

Table 14: Orthobiologic Procedures, Germany, 2015-2022 36

Table 15: Orthobiologic Procedures, Germany, 2023-2030 38

Table 16: Bone Grafts and Substitutes Procedures, Germany, 2015-2022 40

Table 17: Bone Grafts and Substitutes Procedures, Germany, 2023-2030 42

Table 18: Bone Growth Stimulators Procedures, Germany, 2015-2022 44

Table 19: Bone Growth Stimulators Procedures, Germany, 2023-2030 46

Table 20: Cartilage Repair Procedures, Germany, 2015-2022 48

Table 21: Cartilage Repair Procedures, Germany, 2023-2030 50

Table 22: Soft Tissue Biologics Procedures, Germany, 2015-2022 52

Table 23: Soft Tissue Biologics Procedures, Germany, 2023-2030 54

Table 24: Orthobiologic Procedures, Italy, 2015-2022 56

Table 25: Orthobiologic Procedures, Italy, 2023-2030 58

Table 26: Bone Grafts and Substitutes Procedures, Italy, 2015-2022 60

Table 27: Bone Grafts and Substitutes Procedures, Italy, 2023-2030 62

Table 28: Bone Growth Stimulators Procedures, Italy, 2015-2022 64

Table 29: Bone Growth Stimulators Procedures, Italy, 2023-2030 66

Table 30: Cartilage Repair Procedures, Italy, 2015-2022 68

Table 31: Cartilage Repair Procedures, Italy, 2023-2030 70

Table 32: Soft Tissue Biologics Procedures, Italy, 2015-2022 72

Table 33: Soft Tissue Biologics Procedures, Italy, 2023-2030 74

Table 34: Orthobiologic Procedures, Spain, 2015-2022 76

Table 35: Orthobiologic Procedures, Spain, 2023-2030 78

Table 36: Bone Grafts and Substitutes Procedures, Spain, 2015-2022 80

Table 37: Bone Grafts and Substitutes Procedures, Spain, 2023-2030 82

Table 38: Bone Growth Stimulators Procedures, Spain, 2015-2022 84

Table 39: Bone Growth Stimulators Procedures, Spain, 2023-2030 86

Table 40: Cartilage Repair Procedures, Spain, 2015-2022 88

Table 41: Cartilage Repair Procedures, Spain, 2023-2030 90

Table 42: Soft Tissue Biologics Procedures, Spain, 2015-2022 92

Table 43: Soft Tissue Biologics Procedures, Spain, 2023-2030 94

Table 44: Orthobiologic Procedures, United Kingdom, 2015-2022 96

Table 45: Orthobiologic Procedures, United Kingdom, 2023-2030 98

Table 46: Bone Grafts and Substitutes Procedures, United Kingdom, 2015-2022 100

Table 47: Bone Grafts and Substitutes Procedures, United Kingdom, 2023-2030 102

Table 48: Bone Growth Stimulators Procedures, United Kingdom, 2015-2022 104

Table 49: Bone Growth Stimulators Procedures, United Kingdom, 2023-2030 106

Table 50: Cartilage Repair Procedures, United Kingdom, 2015-2022 108

Table 51: Cartilage Repair Procedures, United Kingdom, 2023-2030 110

Table 52: Soft Tissue Biologics Procedures, United Kingdom, 2015-2022 112

Table 53: Soft Tissue Biologics Procedures, United Kingdom, 2023-2030 114

Table 54: Total Number of Primary Research Participants, Orthopedic Devices Market, by Country 117

Figures

List of Figures

Figure 1: Orthobiologic Procedures, EU5, 2015-2030 9

Figure 2: Orthobiologic Procedures, EU5, 2015-2022 11

Figure 3: Orthobiologic Procedures, EU5, 2023-2030 13

Figure 4: Orthobiologic Procedures, France, 2015-2022 15

Figure 5: Orthobiologic Procedures, France, 2023-2030 17

Figure 6: Bone Grafts and Substitutes Procedures, France, 2015-2022 19

Figure 7: Bone Grafts and Substitutes Procedures, France, 2023-2030 21

Figure 8: Bone Growth Stimulators Procedures, France, 2015-2022 23

Figure 9: Bone Growth Stimulators Procedures, France, 2023-2030 25

Figure 10: Cartilage Repair Procedures, France, 2015-2022 27

Figure 11: Cartilage Repair Procedures, France, 2023-2030 29

Figure 12: Soft Tissue Biologics Procedures, France, 2015-2022 31

Figure 13: Soft Tissue Biologics Procedures, France, 2023-2030 33

Figure 14: Orthobiologic Procedures, Germany, 2015-2022 35

Figure 15: Orthobiologic Procedures, Germany, 2023-2030 37

Figure 16: Bone Grafts and Substitutes Procedures, Germany, 2015-2022 39

Figure 17: Bone Grafts and Substitutes Procedures, Germany, 2023-2030 41

Figure 18: Bone Growth Stimulators Procedures, Germany, 2015-2022 43

Figure 19: Bone Growth Stimulators Procedures, Germany, 2023-2030 45

Figure 20: Cartilage Repair Procedures, Germany, 2015-2022 47

Figure 21: Cartilage Repair Procedures, Germany, 2023-2030 49

Figure 22: Soft Tissue Biologics Procedures, Germany, 2015-2022 51

Figure 23: Soft Tissue Biologics Procedures, Germany, 2023-2030 53

Figure 24: Orthobiologic Procedures, Italy, 2015-2022 55

Figure 25: Orthobiologic Procedures, Italy, 2023-2030 57

Figure 26: Bone Grafts and Substitutes Procedures, Italy, 2015-2022 59

Figure 27: Bone Grafts and Substitutes Procedures, Italy, 2023-2030 61

Figure 28: Bone Growth Stimulators Procedures, Italy, 2015-2022 63

Figure 29: Bone Growth Stimulators Procedures, Italy, 2023-2030 65

Figure 30: Cartilage Repair Procedures, Italy, 2015-2022 67

Figure 31: Cartilage Repair Procedures, Italy, 2023-2030 69

Figure 32: Soft Tissue Biologics Procedures, Italy, 2015-2022 71

Figure 33: Soft Tissue Biologics Procedures, Italy, 2023-2030 73

Figure 34: Orthobiologic Procedures, Spain, 2015-2022 75

Figure 35: Orthobiologic Procedures, Spain, 2023-2030 77

Figure 36: Bone Grafts and Substitutes Procedures, Spain, 2015-2022 79

Figure 37: Bone Grafts and Substitutes Procedures, Spain, 2023-2030 81

Figure 38: Bone Growth Stimulators Procedures, Spain, 2015-2022 83

Figure 39: Bone Growth Stimulators Procedures, Spain, 2023-2030 85

Figure 40: Cartilage Repair Procedures, Spain, 2015-2022 87

Figure 41: Cartilage Repair Procedures, Spain, 2023-2030 89

Figure 42: Soft Tissue Biologics Procedures, Spain, 2015-2022 91

Figure 43: Soft Tissue Biologics Procedures, Spain, 2023-2030 93

Figure 44: Orthobiologic Procedures, United Kingdom, 2015-2022 95

Figure 45: Orthobiologic Procedures, United Kingdom, 2023-2030 97

Figure 46: Bone Grafts and Substitutes Procedures, United Kingdom, 2015-2022 99

Figure 47: Bone Grafts and Substitutes Procedures, United Kingdom, 2023-2030 101

Figure 48: Bone Growth Stimulators Procedures, United Kingdom, 2015-2022 103

Figure 49: Bone Growth Stimulators Procedures, United Kingdom, 2023-2030 105

Figure 50: Cartilage Repair Procedures, United Kingdom, 2015-2022 107

Figure 51: Cartilage Repair Procedures, United Kingdom, 2023-2030 109

Figure 52: Soft Tissue Biologics Procedures, United Kingdom, 2015-2022 111

Figure 53: Soft Tissue Biologics Procedures, United Kingdom, 2023-2030 113

Frequently asked questions

EU5 Orthobiologic Procedures Count by Segments and Forecast to 2030 standard reports
Currency USD
$3,995

Can be used by individual purchaser only

$11,985

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

EU5 Orthobiologic Procedures Count by Segments and Forecast to 2030 was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at EU5 Orthobiologic Procedures Count by Segments and Forecast to 2030 in real time.

  • Access a live EU5 Orthobiologic Procedures Count by Segments and Forecast to 2030 dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.